ABSTRACT
Conclusion:
Nebulized adrenaline therapy is an effective, cheap, well tolerated and safe medication for respiratory diseases. Nebulized adrenaline treatment can be used safely at the recommended doses.
Results:
In this study, 48 patients were evaluated. There was no significant difference between the pre- and post-treatment levels in terms of vital signs (p>0.05). When electrocardiography were compared before and after treatment, there was no statistically significant difference in p averaging, QRS duration, QTc interval, p wave dispersion, QT and QTc dispersion.
Methods:
Children, who were admitted to the hospital and received nebulized adrenaline treatment, were included in the study. The patients were followed up in terms of development of new findings and monitored in terms of the presence of new symptoms. Vital findings were recorded before nebulized adrenaline treatment and at 15, 60 and 120 minutes of treatment.
Introduction:
Adrenaline is an important medication used in the treatment of various diseases. The nebulized form of adrenaline is used in respiratory diseases. The aim of this study was to evaluate the effects of nebulized adrenaline treatment on cardiac rhythm.
Keywords:
Arrhythmia, children, nebulized adrenaline
References
1Walker DM. Update on epinephrine (adrenaline) for pediatric emergencies. Curr Opin Pediatr. 2009;21:313-9.
2Bagwell T, Hollingsworth A, Thompson T, Abramo T, Huckabee M, et al. Management of Croup in the Emergency Department: The Role of Multidose Nebulized Epinephrine. Pediatr Emerg Care. 2017; 10.1097/PEC.0000000000001276.
3Tapiainen T, Aittoniemi J, Immonen J, Jylkka H, Meinander T, et al. Finnish guidelines for the treatment of laryngitis, wheezing bronchitis and bronchiolitis in children. Acta Paediatr. 2016;105:44-9.
4Foncerrada G, Lima F, Clayton RP, Mlcak RP, Enkhbaatar P, et al. Safety of Nebulized Epinephrine in Smoke Inhalation Injury. J Burn Care Res. 2017;38:396-402.
5Butte MJ, Nguyen BX, Hutchison TJ, Wiggins JW, Ziegler JW. Pediatric myocardial infarction after racemic epinephrine administration. Pediatr. 1999;104:e9.
6Toaimah FH, Al-Ansari K. Life-threatening cardiac arrhythmia after a single dose of nebulized epinephrine in pediatric emergency department. J Trop Pediatr. 2011;57:497-9.
7Bjornson C, Russell K, Vandermeer B, Klassen TP, Johnson DW. Nebulized epinephrine for croup in children. Cochrane Database Syst Rev. 2013;10:CD006619.
8Roosevelt G. Acute Inflammatory Upper Airway Obstruction. In: Kliegman R, Stanton B (eds). Nelson Textbook of Pediatrics. 20 ed. Philadelphia: Elsevier; 2016:2031-5.
9da Silva PS, Fonseca MC, Iglesias SB, Junior EL, de Aguiar VE, et al. Nebulized 0.5, 2.5 and 5 ml L-epinephrine for post-extubation stridor in children: a prospective, randomized, double-blind clinical trial. Intens Care Med. 2012;38:286-93.
10Zhang L, Sanguebsche LS. The safety of nebulization with 3 to 5 ml of adrenaline (1:1000) in children: an evidence based review. J Pediatr (Rio J). 2005;81:193-7.
11Ejzenberg B. Is adrenaline inhalation safe?. J Pediatr (Rio J). 2005;81:353-4.
12Teksam O. Should the recommended dose of epinephrine for severe croup be changed? J Emerg Med. 2010;39:101-2.
13Bengtsson BO, Spink LA, Grone JB. Local facial cutaneous vasoconstriction: an unusual complication of inhaled racemic epinephrine in a neonate. J Perinatol. 2013;33:985-6.